Sartorius AG (SARTF)
226.33
0.00 (0.00%)
USD |
OTCM |
Apr 02, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 15.63B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 30.16% |
| Valuation | |
| PE Ratio | 89.69 |
| PE Ratio (Forward) | |
| PS Ratio | 3.910 |
| Price to Book Value | 4.916 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.8440 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.582 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 82.31% |
Profile
| Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany. |
| URL | http://www.sartorius.com |
| Investor Relations URL | N/A |
| HQ State/Province | Niedersachsen (Lwr Saxony) |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Apr. 23, 2026 |
| Last Earnings Release | Feb. 16, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 30, 2026 |
Profile
| Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany. |
| URL | http://www.sartorius.com |
| Investor Relations URL | N/A |
| HQ State/Province | Niedersachsen (Lwr Saxony) |
| Sector | Health Care |
| Industry | Life Sciences Tools & Services |
| Next Earnings Release | Apr. 23, 2026 |
| Last Earnings Release | Feb. 16, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 30, 2026 |